ReCon Chat with Bob...
Health Care: Drugs
DARA Biosciences Inc. (DARA: NASDAQ)
$0.73 -0.02 | -2.51%
05/24/13 - 01:34 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.74 |
| 52 Week High | 1.38 |
| 52 Week Low | 0.62 |
| Avg. Daily Vol. (Mil) | 0.45 |
| Beta (3 year) | 1.94 |
| Share Related Items | |
| Mkt Cap (Mil) | 18.60 |
| Shares Out (Mil) | 25.00 |
| Float (Mil) | 24.49 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.60 |
| Current Ratio | 6.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 248.64 |
| Price/Book | 1.67 |
| Price/Cash Flow | -1.70 |
| Per Share Data | |
| Earnings | -0.46 |
| Sales | 0.00 |
| Book Value | 0.44 |
| Cash Flow | -0.45 |
| Business Summary | |
|---|---|
| DARA Biosciences, Inc., is a specialty pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care pharmaceutical products. | |
| General Information | |
| 8601 Six Forks Road
Suite 160 Raleigh, NC 27615 |
|
| www.darabiosciences.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 17 | |
| CEO: Dr. David J. Drutz,M.D. | |
| Short Interest | |
| Current Month (Mil) | 1.88 |
| Previous Month (Mil) | 1.75 |
| Short Interest Ratio (Days) | 3.60 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -96.20 |
| Return on Investments | -106.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with DARA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserStan/Gino
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserIf you can't join them,whup...
- Usergarym
Latest DARA Headlines from TheStreet
- 5 Stocks Under $10 Poised to Pop 01.24.13 | 12:01 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 3 Stocks Under $5 Moving Higher 09.13.12 | 02:09 pm
- 5 Stocks Under $10 Set to Soar Higher 08.30.12 | 12:08 pm
- Report From Results Of A Successful Phase II Study For DARA's KRN5500 At ADEPT 03.29.11 | 08:03 am
- DARA BioSciences Filing Shelf Registration Statement To Replace Expiring Registration Statement 03.25.11 | 04:03 pm
- DARA BioSciences Is Selected By MDB Capital Group As A 2011 "Best & Brightest-Company To Watch" 02.23.11 | 08:02 am
- DARA BioSciences To Present At The Wall Street Analyst Forum 22nd Annual Analyst Conference 02.17.11 | 09:02 am
- Agile Companies Like DARA BioSciences Advance Research For New Diabetes Medicines As Incidence Of Disease Relentlessly Increases 02.15.11 | 09:02 am
- Study Results For DARA Biosciences' Lead Drug For Neuropathic Pain, KRN5500, Selected For Presentation By The International Conference On Accelerating The Development Of Enhanced Pain Treatments ("ADEPT") 02.01.11 | 08:02 am
Press Releases for DARA
- DARA BioSciences Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule - Business Wire 02.14.13 | 08:02 am
- DARA BioSciences To Present At 15th Annual BIO CEO & Investor Conference - Business Wire 02.11.13 | 08:02 am
- DARA BioSciences To Present At The 6th Annual OneMedForum Conference - Business Wire 01.08.13 | 08:01 am
- DARA BioSciences To Raise $2.8 Million Pursuant To Securities Purchase Agreement - Business Wire 12.31.12 | 08:12 am
- DARA BioSciences Announces Submission Of KRN5500 To FDA For Orphan Designation - Business Wire 11.29.12 | 08:11 am
- Dara Biosciences Reports Financial Results For The Third Quarter 2012 - Business Wire 11.14.12 | 05:11 pm
- DARA BioSciences Will Present At NYSSA Investing In Life Sciences Conference, November 29 - Business Wire 11.12.12 | 09:11 am
- DARA BioSciences Will Present At Singular Research Conference November 1 - Business Wire 10.29.12 | 03:10 pm
- Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire) - Business Wire 10.22.12 | 06:10 am
- Soltamox, Liquid Version Of Tamoxifen Citrate (Photo: Business Wire) - Business Wire 10.22.12 | 06:10 am
Partner Headlines for DARA
- Benzinga's Small Cap Movers for Friday November 16, 2012 - Benzinga 11.18.12 | 11:11 am
- Benzinga's Microcap Movers for Friday September 14, 2012 - Benzinga 09.15.12 | 08:09 pm
- DARA Biosciences Inks Deal - Analyst Blog - NASDAQ 08.23.12 | 10:08 pm
- DARA Biosciences Inks Deal - Analyst Blog - Zacks 08.23.12 | 07:08 pm
- DARA Bio Starting To Look Interesting - Analyst Blog - Zacks 05.08.12 | 10:05 am
- Morning Market Losers - Benzinga 04.09.12 | 09:04 am
- Morning Market Movers - Benzinga 03.26.12 | 09:03 am
- DARA BioSciences Spiking Higher after Positive Phase I Results - Benzinga 06.28.11 | 09:06 am
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- News Summary - Benzinga 12.29.10 | 09:12 am
